Novacyt S.A.
NCYT.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.77B
Close$
Share Statistics
| Market cap | $2.77 Billion |
|---|---|
| Enterprise Value | $2.77 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.33 |
| Beta | 1.11 |
| Outstanding Shares | 71,742,654 |
Return
| Return on Equity | -180.28% |
|---|---|
| Return on Assets | -89.59% |
| Return on Invested Capital | -47.70% |
Valuation & Multiples
| P/E Ratio | -0.81 |
|---|---|
| PEG | -0.99 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 75.24 |
| Enterprise Value to EBIT | -185.54 |
| Enterprise Value to Net Income | -83 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.55 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
April 29, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Novacyt S.A.
216 employees
CEO: Lyn Dafydd Rees Founded in 2006 and headquartered in Vélizy-Villacoublay, France, Novacyt S.A. and its subsidiaries are actively involved in the full lifecycle of diagnostic products, encompassing development, manufacturing, custom design, and global co...